UNSPSC 51434939: Hydrochlorothiazide/labetalol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434939 Hydrochlorothiazide/labetalol is a Commodity code representing specific pharmaceutical products procured by state and local emergency response and healthcare agencies. State and local governments soliciting under this code are acquiring prescription medications for emergency medical services, typically through fire departments, EMS systems, and public health programs. The scope of work involves supply of finished pharmaceutical products meeting stability, expiration, and regulatory requirements, with vendors responsible for delivery, expiration management, and replacement logistics.

The City of Tampa's Purchasing Department issued an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications for Tampa Fire Rescue in Hillsborough County, Florida, with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The solicitation called for four medication line items totaling approximately 3,530 units—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials—with a nine-month minimum expiration requirement from acceptance, delivery within ten calendar days of order, and vendor warranty covering defects for 365 days. The contract term runs one year with two optional one-year renewals plus up to three unilateral 30-day extensions. The solicitation includes a Small Local Business Enterprise (SLBE) sheltered market designation offering a 5 percent bid discount not to exceed $10,000, and requires vendors to furnish OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation.